These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 10398501)
1. Genetic studies on a mumps vaccine strain associated with meningitis. Brown EG; Wright KE Rev Med Virol; 1998 Jul; 8(3):129-142. PubMed ID: 10398501 [TBL] [Abstract][Full Text] [Related]
2. The Urabe AM9 mumps vaccine is a mixture of viruses differing at amino acid 335 of the hemagglutinin-neuraminidase gene with one form associated with disease. Brown EG; Dimock K; Wright KE J Infect Dis; 1996 Sep; 174(3):619-22. PubMed ID: 8769623 [TBL] [Abstract][Full Text] [Related]
3. Biological characteristics of genetic variants of Urabe AM9 mumps vaccine virus. Wright KE; Dimock K; Brown EG Virus Res; 2000 Mar; 67(1):49-57. PubMed ID: 10773318 [TBL] [Abstract][Full Text] [Related]
4. Presence of lysine at aa 335 of the hemagglutinin-neuraminidase protein of mumps virus vaccine strain Urabe AM9 is not a requirement for neurovirulence. Sauder CJ; Zhang CX; Link MA; Duprex WP; Carbone KM; Rubin SA Vaccine; 2009 Sep; 27(42):5822-9. PubMed ID: 19660591 [TBL] [Abstract][Full Text] [Related]
5. Correlation of genetic variability with safety of mumps vaccine Urabe AM9 strain. Amexis G; Fineschi N; Chumakov K Virology; 2001 Aug; 287(1):234-41. PubMed ID: 11504558 [TBL] [Abstract][Full Text] [Related]
6. Amino acid change 335 E to K affects the sialic-acid-binding and neuraminidase activities of Urabe AM9 mumps virus hemagglutinin-neuraminidase glycoprotein. Reyes-Leyva J; Baños R; Borraz-Argüello M; Santos-López G; Rosas N; Alvarado G; Herrera I; Vallejo V; Tapia-Ramírez J Microbes Infect; 2007 Feb; 9(2):234-40. PubMed ID: 17223599 [TBL] [Abstract][Full Text] [Related]
7. Differential sensitivity to interferon influences the replication and transcription of Urabe AM9 mumps virus variants in nerve cells. Rosas-Murrieta N; Herrera-Camacho I; Vallejo-Ruiz V; Millán-Pérez-Peña L; Cruz C; Tapia-Ramírez J; Santos-López G; Reyes-Leyva J Microbes Infect; 2007 Jun; 9(7):864-72. PubMed ID: 17533145 [TBL] [Abstract][Full Text] [Related]
8. Identification of genetic mutations associated with attenuation and changes in tropism of Urabe mumps virus. Shah D; Vidal S; Link MA; Rubin SA; Wright KE J Med Virol; 2009 Jan; 81(1):130-8. PubMed ID: 19031463 [TBL] [Abstract][Full Text] [Related]
9. Two clones obtained from Urabe AM9 mumps virus vaccine differ in their replicative efficiency in neuroblastoma cells. Santos-López G; Cruz C; Pazos N; Vallejo V; Reyes-Leyva J; Tapia-Ramírez J Microbes Infect; 2006 Feb; 8(2):332-9. PubMed ID: 16298153 [TBL] [Abstract][Full Text] [Related]
10. Adverse events associated with MMR vaccines in Japan. Kimura M; Kuno-Sakai H; Yamazaki S; Yamada A; Hishiyama M; Kamiya H; Ueda K; Murase T; Hirayama M; Oya A; Nozaki S; Murata R Acta Paediatr Jpn; 1996 Jun; 38(3):205-11. PubMed ID: 8741307 [TBL] [Abstract][Full Text] [Related]
11. Nucleotide sequence analysis of Urabe mumps vaccine strain that caused meningitis in vaccine recipients. Brown EG; Furesz J; Dimock K; Yarosh W; Contreras G Vaccine; 1991 Nov; 9(11):840-2. PubMed ID: 1759507 [TBL] [Abstract][Full Text] [Related]
12. Aseptic meningitis as a complication of mumps vaccination. Sugiura A; Yamada A Pediatr Infect Dis J; 1991 Mar; 10(3):209-13. PubMed ID: 2041668 [TBL] [Abstract][Full Text] [Related]
13. Aseptic meningitis following mumps vaccine. A retrospective survey by the French Regional Pharmacovigilance centres and by Pasteur-Mérieux Sérums & Vaccins. Jonville-Bera AP; Autret E; Galy-Eyraud C; Hessel L Pharmacoepidemiol Drug Saf; 1996 Jan; 5(1):33-7. PubMed ID: 15088275 [TBL] [Abstract][Full Text] [Related]
14. Isolation and characterization of mumps virus strains in a mumps outbreak with a high incidence of aseptic meningitis. Saito H; Takahashi Y; Harata S; Tanaka K; Sano T; Suto T; Yamada A; Yamazaki S; Morita M Microbiol Immunol; 1996; 40(4):271-5. PubMed ID: 8709862 [TBL] [Abstract][Full Text] [Related]
15. Risks of convulsion and aseptic meningitis following measles-mumps-rubella vaccination in the United Kingdom. Miller E; Andrews N; Stowe J; Grant A; Waight P; Taylor B Am J Epidemiol; 2007 Mar; 165(6):704-9. PubMed ID: 17204517 [TBL] [Abstract][Full Text] [Related]
16. Cloning and sequencing of the F gene of live attenuated Urabe Am9 mumps virus. Cusi MG; Bianchi S; Valassina M; Santini L; Valensin PE Gene; 1995 Aug; 161(2):297-8. PubMed ID: 7665098 [TBL] [Abstract][Full Text] [Related]
18. Comparison of the nucleotide sequence of the SH gene and flanking regions of mumps vaccine virus (Urabe strain) grown on different substrates and isolated from vaccinees. Turner PC; Forsey T; Minor PD J Gen Virol; 1991 Feb; 72 ( Pt 2)():435-7. PubMed ID: 1993881 [TBL] [Abstract][Full Text] [Related]
19. Risk of aseptic meningitis after measles, mumps, and rubella vaccine in UK children. Miller E; Goldacre M; Pugh S; Colville A; Farrington P; Flower A; Nash J; MacFarlane L; Tettmar R Lancet; 1993 Apr; 341(8851):979-82. PubMed ID: 8096942 [TBL] [Abstract][Full Text] [Related]
20. Changes in mumps virus neurovirulence phenotype associated with quasispecies heterogeneity. Sauder CJ; Vandenburgh KM; Iskow RC; Malik T; Carbone KM; Rubin SA Virology; 2006 Jun; 350(1):48-57. PubMed ID: 16494912 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]